Rules › DEA-2026-1091
Schedules of Controlled Substances: Placement of Tianeptine in Schedule I
Proposed rule from the Justice Department, Drug Enforcement Administration (docket DEA-2026-1091). 3 comment letters from companies and organizations are listed below.
- Agency
- Justice Department, Drug Enforcement Administration
- Docket
- DEA-2026-1091
- Published
- 2026-07-08
- Comments due
- 2026-08-07
- Status
- Comment period closed August 7, 2026 · no final rule found yet
- Total public comments
- 188
- Letters listed here
- 3
Federal Register notice ↗ · Docket on Regulations.gov ↗
Who commented, by industry
Pharma & Medical Devices 2 Other 1